SlideShare a Scribd company logo
SKELETAL MUSCLE
RELAXANTS
DR. D. K. KATIYAR
1
Where to use
As adjuvant in surgical anaesthesia to
obtained relaxation of skeletal muscle
Relaxation of skeletal muscle to make
operative manipulations easy.
Endotracheal intubation.
Counteract laryngospasm during
barbiturate anaesthesia.
Require lighter level of anaesthesia.
Shorten post-anaesthesia recovery period.
2
Cerebral palsy
Multiple sclerosis
Amyotrophic lateral sclerosis
Spinal injuries
Trigeminal neuralgia
Malignant hyperthermia
Muscle spasm of local origin
Spondylitis
Sprains
lumbago
3
4
4/11/2023
5
Classification on basis of site of action and
mechanism of action
A) Peripherally Acting
Acts at N-M junction fall into two catagories :
i- Non depolarizing (Competitive blockers)- prevent access of
Ach at Nm rec of motor end plate- prevent depolarization
a). Long acting
 Pancuronuium, Doxacurium, Pipecuronium
b). Intermediate acting
 Vecuronium, Atracurium, Rocuronium
c). Short acting
 Mivacurium, Rapacuronium
ii-Depolarizing:
Act as agonists at acetylcholine receptors.
6
B) Centrally acting (spasmolytic drugs)
Selective action in the cerebrospinal axis.
Carisoprodol, Chlorzoxazone, Chlormezanone,
Methocarbamol
Diazepam, Clonazepam ( act through GABA A
receptors)
Baclofen (GABA B receptors)
Tizanidine (central α2 agonist)
C) Directing acting (spasmolytic drugs)
Dantroline ( act directly by interfering release
of calcium from sarcoplasmic reticulum)
7
8
Mechanism of Sk. muscle
contraction
Initiation of impulse
Release of acetylcholine
Activation of nicotinic receptor at motor end
plate
Opening of ion channel, passage of Na+ ,
depolarization of end plate
Muscle contraction.
Neuromuscular Junction
1: Cholinergic motor
neurone
2: motor end-plate
3: vesicles
4: NMR
10
Mechanism of action
(non depolarizing agents)
a) At low doses:
These drugs combine with nicotinic receptors
and prevent acetylcholine binding. As they
compete with acetylcholine for receptor
binding they are called competitive blockers.
Thus prevent depolarization at end-plate.
Hence inhibit muscle contraction, relaxation of
skeletal muscle occurs.
Their action can be overcome by increasing
conc. of acetylcholine in the synaptic gap (by
ihibition of acetyle choline estrase enzyme,
e.g.: Neostigmine ,physostigmine )
Anaesthetist can apply this strategy to shorten
the duration of blockage or overcome the over
dosage.
11
12
At high doses
These drugs block ion channels of the end
plate.
Leads to further weakening of the
transmission and reduces the ability of Ach-
esterase inhibitors to reverse the action.
13
ACTIONS
All the muscles are not equally sensitive to
blockade.
Small and rapidly contracting muscles are
paralyzed first.
Respiratory muscles are last to be affected and
first to recover.
14
Pharmacokinetics:
Administered intravenously (not absorbed
orally as they remain ionized at physiological
pH).
Cross blood brain barrier poorly (they are
poorly lipid soluble)
They have limited volume of distribution as
they are highly ionized.
Drugs excreted by kidney
-Longer duration of action (35-100min)
Drugs eliminated by liver
-Intermediate duration of action (25-50min)
Drugs inactivated spontaneously in plasma
(Hoffmann elimination)
-Intermediate duration of action (25-50min)
Drugs inactivated by plasma cholinesterase
-Shorter duration of action (15-20min)
15
Atracurium is degraded spontaneously in
plasma by ester hydrolysis
it releases histamine and can produce a fall in
blood pressure ,flushing and
bronchoconstriction.
Its metabolite can provoke seizures.
Cisatracurium with similar pharmacokinetics is
more safer.
16
17
Drug interactions
Choline esterase inhibitors such as neostigmine,
pyridostimine and edrophonium reduces or overcome
their activity but with high doses they can cause
depolarizing block due to elevated acetylcholine
concentration at the end plate.
Halothane, aminoglycosides , calcium channel
blockers synergize their effect.
18
Unwanted effects
Fall in arterial pressure- chiefly a result to ganglion
block , may also be due to histamine release .
Bronchospasm due to histamine release from mast
cells (especially with tubocurarine ,mivacurium ,and
atracurium).
Pancuronium block muscarinic receptors also,
particularly in heart which may results tachycardia.
Hypoxia and respiratory paralysis.
19
DEPOLARIZING AGENTS
DRUG- Succinylcholine
Mechanism of action:
act like acetylcholine but persist at the synapse at high
concentration and for longer duration and constantly stimulate
the receptor.
First, opening of the Na+ channel occurs resulting in
depolarization, this leads to transient twitching of the muscle,
continued binding of drugs make the receptor incapable to
transmit the impulses, paralysis occurs.
The continued depolarization makes the receptor incapable of
transmitting further impulses.
20
Therapeutic uses:
When rapid endotracheal intubations is required.
Bronchoscopy
laryngoscopy
Electroconvulsive shock therapy.
Pharmacokinetics:
Administered intravenously.
Due to rapid inactivation by plasma cholinestrase,
given by continued infusion.
21
Succinylcholine (cont)
• It causes paralysis of skeletal muscle.
Sequence of paralysis may be different from that of
non depolarizing drugs but respiratory muscles are
paralyzed last.
Produces a transient twitching of skeletal muscle
before causing block.
It causes maintained depolarization at the end plate,
which leads to a loss of electrical excitability.
It has shorter duration of action (5-10 min).
22
It stimulate ganglion (sympathetic and para
sympathetic both).
In low dose it produces negative ionotropic
and chronotropic effect
In high dose it produces positive ionotropic
and chronotropic effect.
23
It act like acetylcholine but diffuse slowly to
the end plate and remain there for long enough
that the depolarization causes loss of electrical
excitability
If cholinestrase is inhibited ,it is possible for
circulating acetylcholine to reach a level
sufficient to cause depolarization block.
24
Unwanted effects:
Bradycardia (preventable by atropine).
Hyperkalemia in patients with trauma or burns.
this may cause arrhythmia or even cardiac arrest.
Increase intraocular pressure due to contracture of
extra ocular muscles .
increase intragastric pressure which may lead to
emesis and aspiration of gastric content.
25
Malignant hyperthermia: rare inherited condition
probably caused by a mutation of Ca++ release
channel of sarcoplasmic reticulum, which results
muscle spasm and dramatic rise in body temperature.
(This is treated by cooling the body and administration of Dantrolene)
Prolonged paralysis: due to factors which reduce the
activity of plasma cholinesterase
genetic variants as abnormal cholinesterase, its severe
deficiency.
anti -cholinesterase drugs
neonates
liver disease
26
4/11/2023
Characteristics of neuromuscular-blocking drugs
27
Some properties of neuromuscular blockers
Drug Elimination Approximate potency
relative to Tubocurarine
Atracurium spontaneous 1.5
Doxacurium kidney 6
Mivacurium Plasma cholinesterase 4
Metocurine Kidney 40% 4
Tubocurarine Kidney 40% 1
Panacurium Kidney 80% 6
Rocuronium Liver 70-80%,kidney 0.8
vecuronium Liver 75-90%,kidney 6
pipecuronium Kidney ,liver 6
Rapacuronium liver 0.4
28
4/11/2023
Centrally acting muscle relaxants
(Spasmolytic Drugs)
Mephenesin group-
Carisoprodol, Chlorzoxazone, Chlormezanone,
Methocarbamol
Diazepam, Clonazepam ( act through GABA A
receptors)
Baclofen (GABA B receptors)
Tizanidine (central α2 agonist)
29
Mechanisms underlying spasticity involve
- stretch reflex arc itself
-also higher centers in the CNS (ie, upper
motor neuron lesion), with damage to
descending pathways in the spinal cord
resulting in hyperexcitability of the alpha
motoneurons in the cord.
30
Pharmacologic therapy
- ameliorate some of the symptoms of
spasticity by modifying the stretch reflex
arc
-or by interfering directly with skeletal
muscle (ie, excitation-contraction
coupling).
31
32
Baclofen
It acts through GABA- B receptors
It causes hyper polarization by increased K+ conductance,
reducing calcium influx and reduces excitatory transmitter in brain
as well as spinal cord
It also reduces pain by inhibitory substance P. in spinal cord
It is less sedative
It is rapidly and completely absorbed orally
It has a half life of 3- 4 hours
It may increases seizures in epileptics
It is also useful to prevent migraine.
Tizanidine
Tizanidine has significant (α2), -
adrenoceptor agonist effects
tizanidine reinforces both presynaptic and
postsynaptic inhibition in the cord.
It also inhibits nociceptive transmission in
the spinal dorsal horn.
33
34
Dantrolene
It acts directly
It reduces skeletal muscle strength by interfering with
excitation-contraction coupling into the muscle fiber,
by inhibiting the release of activator calcium from the
sarcoplasmic stores.
It is very useful in the treatment of malignant
hyperthermia caused by depolarizing relaxants.
This drug can be administered orally as well as
intravenously. Oral absorption is only one third.
Half life of the drug is 8-9 hours.
Sites of spasmolytic action of tizanidine (α2), benzodiazepines (GABAA), and
baclofen (GABAB) in the spinal cord. Tizanidine may also have a postsynaptic
inhibitory effect. Dantrolene acts on the sarcoplasmic reticulum in skeletal
muscle. Glu, glutamatergic neuron.
Thank you
36

More Related Content

Similar to SKELETAL_MUSCLE_RELAXANTS.ppt

Skeletal muscle relaxants - drdhriti
Skeletal muscle relaxants - drdhritiSkeletal muscle relaxants - drdhriti
Skeletal muscle relaxants - drdhriti
http://neigrihms.gov.in/
 
Periphral acting muscle relaxant & nm blocking agents
Periphral acting muscle relaxant & nm blocking agentsPeriphral acting muscle relaxant & nm blocking agents
Periphral acting muscle relaxant & nm blocking agents
Satyajit Ghosh
 
muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses
Indian dental academy
 
Copy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant coursesCopy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant courses
Indian dental academy
 
DRUGS AFFECTING SKELETAL MUSCLES.pptx
DRUGS AFFECTING SKELETAL MUSCLES.pptxDRUGS AFFECTING SKELETAL MUSCLES.pptx
DRUGS AFFECTING SKELETAL MUSCLES.pptx
MuhammadMansoorAlamK
 
Neuromuscular junction pharmacology, drugs used
Neuromuscular junction pharmacology, drugs usedNeuromuscular junction pharmacology, drugs used
Neuromuscular junction pharmacology, drugs used
swaroopbankolli
 
lecture 13- Skeletal muscle relaxants.ppt
lecture 13- Skeletal muscle relaxants.pptlecture 13- Skeletal muscle relaxants.ppt
lecture 13- Skeletal muscle relaxants.ppt
AbdallahAlasal1
 
Smooth muscle relaxants
Smooth muscle relaxantsSmooth muscle relaxants
Smooth muscle relaxants
Kalaivanisathishr
 
Neuromuscular blocking agents By Sardar Saud abbas
Neuromuscular blocking agents By Sardar Saud abbasNeuromuscular blocking agents By Sardar Saud abbas
Neuromuscular blocking agents By Sardar Saud abbas
Khyber Teaching hospital
 
SKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTSSKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTS
Mahi Yeruva
 
Drugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptxDrugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptx
Manish Gautam
 
Neuromuscular blocker
Neuromuscular blockerNeuromuscular blocker
Neuromuscular blocker
Omkumar Patel
 
NMB.pptx
NMB.pptxNMB.pptx
NMB.pptx
adnanali979088
 
Sk. Muscle Relaxantsnursing and its side effects
Sk. Muscle Relaxantsnursing and its side effectsSk. Muscle Relaxantsnursing and its side effects
Sk. Muscle Relaxantsnursing and its side effects
wajidullah9551
 
Pharmacology: Skeletal Muscle Relaxants
Pharmacology: Skeletal Muscle RelaxantsPharmacology: Skeletal Muscle Relaxants
Pharmacology: Skeletal Muscle Relaxants
Sarah Abu El-Asrar
 
SKELETAL MUSCLE RELAXENT.pptx
SKELETAL MUSCLE RELAXENT.pptxSKELETAL MUSCLE RELAXENT.pptx
SKELETAL MUSCLE RELAXENT.pptx
ValiantVenkat1
 
Muscle relaxant and reversal agents
Muscle relaxant and reversal agentsMuscle relaxant and reversal agents
Muscle relaxant and reversal agents
Pranav Bansal
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants

Similar to SKELETAL_MUSCLE_RELAXANTS.ppt (20)

Skeletal muscle relaxants - drdhriti
Skeletal muscle relaxants - drdhritiSkeletal muscle relaxants - drdhriti
Skeletal muscle relaxants - drdhriti
 
Periphral acting muscle relaxant & nm blocking agents
Periphral acting muscle relaxant & nm blocking agentsPeriphral acting muscle relaxant & nm blocking agents
Periphral acting muscle relaxant & nm blocking agents
 
muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses muscle relaxants / oral surgery courses
muscle relaxants / oral surgery courses
 
Copy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant coursesCopy of skeletal muscle relaxants / dental implant courses
Copy of skeletal muscle relaxants / dental implant courses
 
DRUGS AFFECTING SKELETAL MUSCLES.pptx
DRUGS AFFECTING SKELETAL MUSCLES.pptxDRUGS AFFECTING SKELETAL MUSCLES.pptx
DRUGS AFFECTING SKELETAL MUSCLES.pptx
 
Neuromuscular junction pharmacology, drugs used
Neuromuscular junction pharmacology, drugs usedNeuromuscular junction pharmacology, drugs used
Neuromuscular junction pharmacology, drugs used
 
lecture 13- Skeletal muscle relaxants.ppt
lecture 13- Skeletal muscle relaxants.pptlecture 13- Skeletal muscle relaxants.ppt
lecture 13- Skeletal muscle relaxants.ppt
 
Smooth muscle relaxants
Smooth muscle relaxantsSmooth muscle relaxants
Smooth muscle relaxants
 
Neuromuscular blocking agents By Sardar Saud abbas
Neuromuscular blocking agents By Sardar Saud abbasNeuromuscular blocking agents By Sardar Saud abbas
Neuromuscular blocking agents By Sardar Saud abbas
 
SKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTSSKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTS
 
Drugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptxDrugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptx
 
Neuromuscular blocker
Neuromuscular blockerNeuromuscular blocker
Neuromuscular blocker
 
Neuromuscular blocking
Neuromuscular blockingNeuromuscular blocking
Neuromuscular blocking
 
NMB.pptx
NMB.pptxNMB.pptx
NMB.pptx
 
Sk. Muscle Relaxantsnursing and its side effects
Sk. Muscle Relaxantsnursing and its side effectsSk. Muscle Relaxantsnursing and its side effects
Sk. Muscle Relaxantsnursing and its side effects
 
Pharmacology: Skeletal Muscle Relaxants
Pharmacology: Skeletal Muscle RelaxantsPharmacology: Skeletal Muscle Relaxants
Pharmacology: Skeletal Muscle Relaxants
 
SKELETAL MUSCLE RELAXENT.pptx
SKELETAL MUSCLE RELAXENT.pptxSKELETAL MUSCLE RELAXENT.pptx
SKELETAL MUSCLE RELAXENT.pptx
 
Muscle relaxant and reversal agents
Muscle relaxant and reversal agentsMuscle relaxant and reversal agents
Muscle relaxant and reversal agents
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
 

More from Imtiyaz60

Thyroid_disorders_presentation (2).pptx
Thyroid_disorders_presentation  (2).pptxThyroid_disorders_presentation  (2).pptx
Thyroid_disorders_presentation (2).pptx
Imtiyaz60
 
asthma .pptx
asthma                                             .pptxasthma                                             .pptx
asthma .pptx
Imtiyaz60
 
Asthma and COPD PATHOPHYSIOLOGY .pptx
Asthma and COPD PATHOPHYSIOLOGY    .pptxAsthma and COPD PATHOPHYSIOLOGY    .pptx
Asthma and COPD PATHOPHYSIOLOGY .pptx
Imtiyaz60
 
Angina and MI PATHOPHYSIOLOGY .pdf
Angina and MI PATHOPHYSIOLOGY       .pdfAngina and MI PATHOPHYSIOLOGY       .pdf
Angina and MI PATHOPHYSIOLOGY .pdf
Imtiyaz60
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptx
Imtiyaz60
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
Imtiyaz60
 
Hypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptxHypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptx
Imtiyaz60
 
Appetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptxAppetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptx
Imtiyaz60
 
Anti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classificationAnti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classification
Imtiyaz60
 
gingerasafoetida.pptx
gingerasafoetida.pptxgingerasafoetida.pptx
gingerasafoetida.pptx
Imtiyaz60
 
leprosy.pptx
leprosy.pptxleprosy.pptx
leprosy.pptx
Imtiyaz60
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
Imtiyaz60
 
strokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptxstrokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptx
Imtiyaz60
 
Thyroid gland.pptx
Thyroid gland.pptxThyroid gland.pptx
Thyroid gland.pptx
Imtiyaz60
 
inflammatory bowel diseas.pptx
inflammatory bowel diseas.pptxinflammatory bowel diseas.pptx
inflammatory bowel diseas.pptx
Imtiyaz60
 
tannins-170116185017.pptx
tannins-170116185017.pptxtannins-170116185017.pptx
tannins-170116185017.pptx
Imtiyaz60
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
Imtiyaz60
 
tuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptxtuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptx
Imtiyaz60
 
2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt
Imtiyaz60
 
Electrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptxElectrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptx
Imtiyaz60
 

More from Imtiyaz60 (20)

Thyroid_disorders_presentation (2).pptx
Thyroid_disorders_presentation  (2).pptxThyroid_disorders_presentation  (2).pptx
Thyroid_disorders_presentation (2).pptx
 
asthma .pptx
asthma                                             .pptxasthma                                             .pptx
asthma .pptx
 
Asthma and COPD PATHOPHYSIOLOGY .pptx
Asthma and COPD PATHOPHYSIOLOGY    .pptxAsthma and COPD PATHOPHYSIOLOGY    .pptx
Asthma and COPD PATHOPHYSIOLOGY .pptx
 
Angina and MI PATHOPHYSIOLOGY .pdf
Angina and MI PATHOPHYSIOLOGY       .pdfAngina and MI PATHOPHYSIOLOGY       .pdf
Angina and MI PATHOPHYSIOLOGY .pdf
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptx
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
 
Hypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptxHypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptx
 
Appetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptxAppetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptx
 
Anti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classificationAnti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classification
 
gingerasafoetida.pptx
gingerasafoetida.pptxgingerasafoetida.pptx
gingerasafoetida.pptx
 
leprosy.pptx
leprosy.pptxleprosy.pptx
leprosy.pptx
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
 
strokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptxstrokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptx
 
Thyroid gland.pptx
Thyroid gland.pptxThyroid gland.pptx
Thyroid gland.pptx
 
inflammatory bowel diseas.pptx
inflammatory bowel diseas.pptxinflammatory bowel diseas.pptx
inflammatory bowel diseas.pptx
 
tannins-170116185017.pptx
tannins-170116185017.pptxtannins-170116185017.pptx
tannins-170116185017.pptx
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
tuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptxtuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptx
 
2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt
 
Electrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptxElectrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptx
 

Recently uploaded

June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 

Recently uploaded (20)

June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 

SKELETAL_MUSCLE_RELAXANTS.ppt

  • 2. Where to use As adjuvant in surgical anaesthesia to obtained relaxation of skeletal muscle Relaxation of skeletal muscle to make operative manipulations easy. Endotracheal intubation. Counteract laryngospasm during barbiturate anaesthesia. Require lighter level of anaesthesia. Shorten post-anaesthesia recovery period. 2
  • 3. Cerebral palsy Multiple sclerosis Amyotrophic lateral sclerosis Spinal injuries Trigeminal neuralgia Malignant hyperthermia Muscle spasm of local origin Spondylitis Sprains lumbago 3
  • 5. 5 Classification on basis of site of action and mechanism of action A) Peripherally Acting Acts at N-M junction fall into two catagories : i- Non depolarizing (Competitive blockers)- prevent access of Ach at Nm rec of motor end plate- prevent depolarization a). Long acting  Pancuronuium, Doxacurium, Pipecuronium b). Intermediate acting  Vecuronium, Atracurium, Rocuronium c). Short acting  Mivacurium, Rapacuronium ii-Depolarizing: Act as agonists at acetylcholine receptors.
  • 6. 6 B) Centrally acting (spasmolytic drugs) Selective action in the cerebrospinal axis. Carisoprodol, Chlorzoxazone, Chlormezanone, Methocarbamol Diazepam, Clonazepam ( act through GABA A receptors) Baclofen (GABA B receptors) Tizanidine (central α2 agonist)
  • 7. C) Directing acting (spasmolytic drugs) Dantroline ( act directly by interfering release of calcium from sarcoplasmic reticulum) 7
  • 8. 8 Mechanism of Sk. muscle contraction Initiation of impulse Release of acetylcholine Activation of nicotinic receptor at motor end plate Opening of ion channel, passage of Na+ , depolarization of end plate Muscle contraction.
  • 9. Neuromuscular Junction 1: Cholinergic motor neurone 2: motor end-plate 3: vesicles 4: NMR
  • 10. 10 Mechanism of action (non depolarizing agents) a) At low doses: These drugs combine with nicotinic receptors and prevent acetylcholine binding. As they compete with acetylcholine for receptor binding they are called competitive blockers. Thus prevent depolarization at end-plate. Hence inhibit muscle contraction, relaxation of skeletal muscle occurs.
  • 11. Their action can be overcome by increasing conc. of acetylcholine in the synaptic gap (by ihibition of acetyle choline estrase enzyme, e.g.: Neostigmine ,physostigmine ) Anaesthetist can apply this strategy to shorten the duration of blockage or overcome the over dosage. 11
  • 12. 12 At high doses These drugs block ion channels of the end plate. Leads to further weakening of the transmission and reduces the ability of Ach- esterase inhibitors to reverse the action.
  • 13. 13 ACTIONS All the muscles are not equally sensitive to blockade. Small and rapidly contracting muscles are paralyzed first. Respiratory muscles are last to be affected and first to recover.
  • 14. 14 Pharmacokinetics: Administered intravenously (not absorbed orally as they remain ionized at physiological pH). Cross blood brain barrier poorly (they are poorly lipid soluble) They have limited volume of distribution as they are highly ionized.
  • 15. Drugs excreted by kidney -Longer duration of action (35-100min) Drugs eliminated by liver -Intermediate duration of action (25-50min) Drugs inactivated spontaneously in plasma (Hoffmann elimination) -Intermediate duration of action (25-50min) Drugs inactivated by plasma cholinesterase -Shorter duration of action (15-20min) 15
  • 16. Atracurium is degraded spontaneously in plasma by ester hydrolysis it releases histamine and can produce a fall in blood pressure ,flushing and bronchoconstriction. Its metabolite can provoke seizures. Cisatracurium with similar pharmacokinetics is more safer. 16
  • 17. 17 Drug interactions Choline esterase inhibitors such as neostigmine, pyridostimine and edrophonium reduces or overcome their activity but with high doses they can cause depolarizing block due to elevated acetylcholine concentration at the end plate. Halothane, aminoglycosides , calcium channel blockers synergize their effect.
  • 18. 18 Unwanted effects Fall in arterial pressure- chiefly a result to ganglion block , may also be due to histamine release . Bronchospasm due to histamine release from mast cells (especially with tubocurarine ,mivacurium ,and atracurium). Pancuronium block muscarinic receptors also, particularly in heart which may results tachycardia. Hypoxia and respiratory paralysis.
  • 19. 19 DEPOLARIZING AGENTS DRUG- Succinylcholine Mechanism of action: act like acetylcholine but persist at the synapse at high concentration and for longer duration and constantly stimulate the receptor. First, opening of the Na+ channel occurs resulting in depolarization, this leads to transient twitching of the muscle, continued binding of drugs make the receptor incapable to transmit the impulses, paralysis occurs. The continued depolarization makes the receptor incapable of transmitting further impulses.
  • 20. 20 Therapeutic uses: When rapid endotracheal intubations is required. Bronchoscopy laryngoscopy Electroconvulsive shock therapy. Pharmacokinetics: Administered intravenously. Due to rapid inactivation by plasma cholinestrase, given by continued infusion.
  • 21. 21 Succinylcholine (cont) • It causes paralysis of skeletal muscle. Sequence of paralysis may be different from that of non depolarizing drugs but respiratory muscles are paralyzed last. Produces a transient twitching of skeletal muscle before causing block. It causes maintained depolarization at the end plate, which leads to a loss of electrical excitability. It has shorter duration of action (5-10 min).
  • 22. 22 It stimulate ganglion (sympathetic and para sympathetic both). In low dose it produces negative ionotropic and chronotropic effect In high dose it produces positive ionotropic and chronotropic effect.
  • 23. 23 It act like acetylcholine but diffuse slowly to the end plate and remain there for long enough that the depolarization causes loss of electrical excitability If cholinestrase is inhibited ,it is possible for circulating acetylcholine to reach a level sufficient to cause depolarization block.
  • 24. 24 Unwanted effects: Bradycardia (preventable by atropine). Hyperkalemia in patients with trauma or burns. this may cause arrhythmia or even cardiac arrest. Increase intraocular pressure due to contracture of extra ocular muscles . increase intragastric pressure which may lead to emesis and aspiration of gastric content.
  • 25. 25 Malignant hyperthermia: rare inherited condition probably caused by a mutation of Ca++ release channel of sarcoplasmic reticulum, which results muscle spasm and dramatic rise in body temperature. (This is treated by cooling the body and administration of Dantrolene) Prolonged paralysis: due to factors which reduce the activity of plasma cholinesterase genetic variants as abnormal cholinesterase, its severe deficiency. anti -cholinesterase drugs neonates liver disease
  • 27. 27 Some properties of neuromuscular blockers Drug Elimination Approximate potency relative to Tubocurarine Atracurium spontaneous 1.5 Doxacurium kidney 6 Mivacurium Plasma cholinesterase 4 Metocurine Kidney 40% 4 Tubocurarine Kidney 40% 1 Panacurium Kidney 80% 6 Rocuronium Liver 70-80%,kidney 0.8 vecuronium Liver 75-90%,kidney 6 pipecuronium Kidney ,liver 6 Rapacuronium liver 0.4
  • 29. Centrally acting muscle relaxants (Spasmolytic Drugs) Mephenesin group- Carisoprodol, Chlorzoxazone, Chlormezanone, Methocarbamol Diazepam, Clonazepam ( act through GABA A receptors) Baclofen (GABA B receptors) Tizanidine (central α2 agonist) 29
  • 30. Mechanisms underlying spasticity involve - stretch reflex arc itself -also higher centers in the CNS (ie, upper motor neuron lesion), with damage to descending pathways in the spinal cord resulting in hyperexcitability of the alpha motoneurons in the cord. 30
  • 31. Pharmacologic therapy - ameliorate some of the symptoms of spasticity by modifying the stretch reflex arc -or by interfering directly with skeletal muscle (ie, excitation-contraction coupling). 31
  • 32. 32 Baclofen It acts through GABA- B receptors It causes hyper polarization by increased K+ conductance, reducing calcium influx and reduces excitatory transmitter in brain as well as spinal cord It also reduces pain by inhibitory substance P. in spinal cord It is less sedative It is rapidly and completely absorbed orally It has a half life of 3- 4 hours It may increases seizures in epileptics It is also useful to prevent migraine.
  • 33. Tizanidine Tizanidine has significant (α2), - adrenoceptor agonist effects tizanidine reinforces both presynaptic and postsynaptic inhibition in the cord. It also inhibits nociceptive transmission in the spinal dorsal horn. 33
  • 34. 34 Dantrolene It acts directly It reduces skeletal muscle strength by interfering with excitation-contraction coupling into the muscle fiber, by inhibiting the release of activator calcium from the sarcoplasmic stores. It is very useful in the treatment of malignant hyperthermia caused by depolarizing relaxants. This drug can be administered orally as well as intravenously. Oral absorption is only one third. Half life of the drug is 8-9 hours.
  • 35. Sites of spasmolytic action of tizanidine (α2), benzodiazepines (GABAA), and baclofen (GABAB) in the spinal cord. Tizanidine may also have a postsynaptic inhibitory effect. Dantrolene acts on the sarcoplasmic reticulum in skeletal muscle. Glu, glutamatergic neuron.